APBD
MCID: ADL060
MIFTS: 32

Adult Polyglucosan Body Disease (APBD)

Categories: Mental diseases, Nephrological diseases, Neuronal diseases, Rare diseases

Aliases & Classifications for Adult Polyglucosan Body Disease

MalaCards integrated aliases for Adult Polyglucosan Body Disease:

Name: Adult Polyglucosan Body Disease 25 54 26
Polyglucosan Body Disease, Adult Form 54 26 74
Polyglucosan Body Disease, Adult 30 6 41
Apbd 54 26
Polyglucosan Body Neuropathy, Adult Form 54
Apbn 54

Classifications:



Summaries for Adult Polyglucosan Body Disease

NIH Rare Diseases : 54 Adult polyglucosan body disease (APBD) affects the nervous system. People with this disease usually begin to show signs after the age of 40. Signs and symptoms include trouble walking due to peripheral neuropathy and muscle weakness and stiffness. People with APBD also develop problems with bladder control due to damage to the bladder's nerves (neurogenic bladder). About half of people with APBD also develop dementia. APBD can be caused by mutations in the GBE1 gene and inheritance is autosomal recessive. In some cases, the cause is not known. Treatment aims to improve quality of life by controlling each symptom of the disease. APBD likely shortens life expectancy, but with symptom management and supportive care, people with APBD can have years of productive life.

MalaCards based summary : Adult Polyglucosan Body Disease, also known as polyglucosan body disease, adult form, is related to polyglucosan body neuropathy, adult form and dementia, and has symptoms including difficulty passing urine and upper motor neuron signs. An important gene associated with Adult Polyglucosan Body Disease is GBE1 (1,4-Alpha-Glucan Branching Enzyme 1). Affiliated tissues include skin, brain and spinal cord, and related phenotypes are intellectual disability and spasticity

Genetics Home Reference : 26 Adult polyglucosan body disease is a condition that affects the nervous system. People with this condition have problems walking due to reduced sensation in their legs (peripheral neuropathy) and progressive muscle weakness and stiffness (spasticity). Damage to the nerves that control bladder function, a condition called neurogenic bladder, causes affected individuals to have progressive difficulty controlling the flow of urine. About half of people with adult polyglucosan body disease experience a decline in intellectual function (dementia).

GeneReviews: NBK5300

Related Diseases for Adult Polyglucosan Body Disease

Diseases related to Adult Polyglucosan Body Disease via text searches within MalaCards or GeneCards Suite gene sharing:

# Related Disease Score Top Affiliating Genes
1 polyglucosan body neuropathy, adult form 12.0
2 dementia 10.3
3 liver disease 10.0
4 plexopathy 10.0
5 tremor 10.0

Graphical network of the top 20 diseases related to Adult Polyglucosan Body Disease:



Diseases related to Adult Polyglucosan Body Disease

Symptoms & Phenotypes for Adult Polyglucosan Body Disease

Human phenotypes related to Adult Polyglucosan Body Disease:

33 (show all 17)
# Description HPO Frequency HPO Source Accession
1 intellectual disability 33 hallmark (90%) HP:0001249
2 spasticity 33 hallmark (90%) HP:0001257
3 gait disturbance 33 hallmark (90%) HP:0001288
4 muscle weakness 33 hallmark (90%) HP:0001324
5 urinary bladder sphincter dysfunction 33 hallmark (90%) HP:0002839
6 urinary incontinence 33 hallmark (90%) HP:0000020
7 hemiparesis 33 hallmark (90%) HP:0001269
8 neurogenic bladder 33 hallmark (90%) HP:0000011
9 abnormal pyramidal sign 33 hallmark (90%) HP:0007256
10 behavioral abnormality 33 frequent (33%) HP:0000708
11 skin ulcer 33 frequent (33%) HP:0200042
12 distal sensory impairment 33 frequent (33%) HP:0002936
13 ataxia 33 occasional (7.5%) HP:0001251
14 emg abnormality 33 occasional (7.5%) HP:0003457
15 limitation of joint mobility 33 occasional (7.5%) HP:0001376
16 dementia 33 occasional (7.5%) HP:0000726
17 abnormality of extrapyramidal motor function 33 occasional (7.5%) HP:0002071

UMLS symptoms related to Adult Polyglucosan Body Disease:


difficulty passing urine, upper motor neuron signs

MGI Mouse Phenotypes related to Adult Polyglucosan Body Disease:

47
# Description MGI Source Accession Score Top Affiliating Genes
1 muscle MP:0005369 8.62 GBE1 TARDBP

Drugs & Therapeutics for Adult Polyglucosan Body Disease

Interventional clinical trials:


# Name Status NCT ID Phase Drugs
1 Triheptanoin Treatment Trial for Patients With Adult Polyglucosan Body Disease Completed NCT00947960 Phase 2 Triheptanoin

Search NIH Clinical Center for Adult Polyglucosan Body Disease

Genetic Tests for Adult Polyglucosan Body Disease

Genetic tests related to Adult Polyglucosan Body Disease:

# Genetic test Affiliating Genes
1 Polyglucosan Body Disease, Adult 30 GBE1

Anatomical Context for Adult Polyglucosan Body Disease

MalaCards organs/tissues related to Adult Polyglucosan Body Disease:

42
Skin, Brain, Spinal Cord, Liver

Publications for Adult Polyglucosan Body Disease

Articles related to Adult Polyglucosan Body Disease:

(show all 49)
# Title Authors Year
1
Guaiacol as a drug candidate for treating adult polyglucosan body disease. ( 30185673 )
2018
2
Novel GBE1 mutation in a Japanese family with adult polyglucosan body disease. ( 28265589 )
2017
3
A novel image-based high-throughput screening assay discovers therapeutic candidates for adult polyglucosan body disease. ( 28827282 )
2017
4
Teaching NeuroImages: Prominent spinal cord atrophy and white matter changes in adult polyglucosan body disease. ( 28507268 )
2017
5
A double-blind, placebo-controlled trial of triheptanoin in adult polyglucosan body disease and open-label, long-term outcome. ( 29110179 )
2017
6
Polyglucosan bodies in intramuscular nerve branches are a poor predictor of GBE1 mutation and adult polyglucosan body disease. ( 26670585 )
2016
7
Adult polyglucosan body disease presenting as a unilateral progressive plexopathy. ( 26789422 )
2016
8
Frequent misdiagnosis of adult polyglucosan body disease. ( 26194201 )
2015
9
A novel GBE1 mutation and features of polyglucosan bodies autophagy in adult polyglucosan body disease. ( 25544507 )
2015
10
Adult Polyglucosan Body Disease: Clinical and histological heterogeneity of a large Italian family. ( 25728520 )
2015
11
Deep Intronic GBE1 Mutation in Manifesting Heterozygous Patients With Adult Polyglucosan Body Disease. ( 25665141 )
2015
12
Adult polyglucosan body disease with GBE1 haploinsufficiency and concomitant frontotemporal lobar degeneration. ( 24750115 )
2014
13
Abnormal glycogen in astrocytes is sufficient to cause adult polyglucosan body disease. ( 23266647 )
2013
14
Adult polyglucosan body disease in a patient originally diagnosed with Fabry's disease. ( 24380807 )
2013
15
Coexisting adult polyglucosan body disease with frontotemporal lobar degeneration with transactivation response DNA-binding protein-43 (TDP-43)-positive neuronal inclusions. ( 22506890 )
2013
16
Acute but transient neurological deterioration revealing adult polyglucosan body disease. ( 23146612 )
2013
17
Adult polyglucosan body disease masquerading as "ALS with dementia of the Alzheimer type": an exceptional phenotype in a rare pathology. ( 21572310 )
2012
18
Adult polyglucosan body disease: Natural History and Key Magnetic Resonance Imaging Findings. ( 23034915 )
2012
19
The adult polyglucosan body disease mutation GBE1 c.1076A>C occurs at high frequency in persons of Ashkenazi Jewish background. ( 22943850 )
2012
20
Adult polyglucosan body disease: a rare presentation with chronic liver disease and ground-glass hepatocellular inclusions. ( 21538287 )
2011
21
Adult Polyglucosan Body Disease (APBD): Anaplerotic diet therapy (Triheptanoin) and demonstration of defective methylation pathways. ( 20655781 )
2010
22
Adult polyglucosan body disease: proton magnetic resonance spectroscopy of the brain and novel mutation in the GBE1 gene. ( 17994551 )
2008
23
Immunohistochemical and ultrastructural changes in the brain in probable adult glycogenosis type IV: adult polyglucosan body disease. ( 18825592 )
2008
24
Stable neuropsychological deficits in adult polyglucosan body disease. ( 16730990 )
2007
25
A case of adult polyglucosan body disease. ( 17722245 )
2007
26
Adult polyglucosan body disease: a case report of a manifesting heterozygote. ( 16007674 )
2005
27
Adult polyglucosan body disease: case description of an expanding genetic and clinical syndrome. ( 14755501 )
2004
28
Adult polyglucosan body disease: a postmortem correlation study. ( 12874416 )
2003
29
Adult polyglucosan body disease associated with lewy bodies and tremor. ( 12756142 )
2003
30
Adult polyglucosan body disease. ( 11260627 )
2001
31
Extensive white-matter changes in case of adult polyglucosan body disease. ( 11305757 )
2001
32
Probable adult polyglucosan body disease. ( 11126844 )
2000
33
Novel missense mutations in the glycogen-branching enzyme gene in adult polyglucosan body disease. ( 10762170 )
2000
34
Adult polyglucosan body disease in Ashkenazi Jewish patients carrying the Tyr329Ser mutation in the glycogen-branching enzyme gene. ( 9851430 )
1998
35
Adult polyglucosan body disease associated with an extrapyramidal syndrome. ( 9810960 )
1998
36
Familial dementia due to adult polyglucosan body disease. ( 9266150 )
1997
37
Sevoflurane anaesthesia for a patient with adult polyglucosan body disease. ( 8955978 )
1996
38
Dementia of frontal lobe type due to adult polyglucosan body disease. ( 8530979 )
1995
39
Adult polyglucosan body disease. ( 7922101 )
1994
40
Dementia of adult polyglucosan body disease. Evidence of cortical and subcortical dysfunction. ( 8274116 )
1994
41
Glycogen branching enzyme deficiency in adult polyglucosan body disease. ( 8494336 )
1993
42
Adult Polyglucosan Body Disease ( 20301758 )
1993
43
Spinal cord MRI in adult polyglucosan body disease. ( 1522280 )
1992
44
Hereditary branching enzyme dysfunction in adult polyglucosan body disease: a possible metabolic cause in two patients. ( 1763891 )
1991
45
Adult polyglucosan body disease: the diagnostic value of axilla skin biopsy. ( 1656844 )
1991
46
Adult polyglucosan body disease (APBD). ( 2838589 )
1988
47
Adult polyglucosan body disease: clinical and nerve biopsy findings in two cases. ( 6301360 )
1983
48
A type of adult polyglucosan body disease. ( 6814164 )
1982
49
A distinct form of adult polyglucosan body disease with massive involvement of central and peripheral neuronal processes and astrocytes: a report of four cases and a review of the occurrence of polyglucosan bodies in other conditions such as Lafora's disease and normal ageing. ( 6249438 )
1980

Variations for Adult Polyglucosan Body Disease

ClinVar genetic disease variations for Adult Polyglucosan Body Disease:

6 (show top 50) (show all 70)
# Gene Variation Type Significance SNP ID Assembly Location
1 GBE1 NM_000158.3(GBE1): c.568A> G (p.Arg190Gly) single nucleotide variant Benign rs2229519 GRCh37 Chromosome 3, 81698130: 81698130
2 GBE1 NM_000158.3(GBE1): c.568A> G (p.Arg190Gly) single nucleotide variant Benign rs2229519 GRCh38 Chromosome 3, 81648979: 81648979
3 GBE1 NM_000158.3(GBE1): c.691+2T> C single nucleotide variant Pathogenic/Likely pathogenic rs192044702 GRCh37 Chromosome 3, 81698005: 81698005
4 GBE1 NM_000158.3(GBE1): c.691+2T> C single nucleotide variant Pathogenic/Likely pathogenic rs192044702 GRCh38 Chromosome 3, 81648854: 81648854
5 GBE1 NM_000158.3(GBE1): c.784C> T (p.Arg262Cys) single nucleotide variant Pathogenic rs137852893 GRCh37 Chromosome 3, 81692140: 81692140
6 GBE1 NM_000158.3(GBE1): c.784C> T (p.Arg262Cys) single nucleotide variant Pathogenic rs137852893 GRCh38 Chromosome 3, 81642989: 81642989
7 GBE1 NM_000158.3(GBE1): c.1716C> T (p.Asp572=) single nucleotide variant Benign/Likely benign rs2229520 GRCh37 Chromosome 3, 81586149: 81586149
8 GBE1 NM_000158.3(GBE1): c.1716C> T (p.Asp572=) single nucleotide variant Benign/Likely benign rs2229520 GRCh38 Chromosome 3, 81536998: 81536998
9 GBE1 NM_000158.3(GBE1): c.1519A> G (p.Thr507Ala) single nucleotide variant Benign/Likely benign rs2228389 GRCh37 Chromosome 3, 81627175: 81627175
10 GBE1 NM_000158.3(GBE1): c.1519A> G (p.Thr507Ala) single nucleotide variant Benign/Likely benign rs2228389 GRCh38 Chromosome 3, 81578024: 81578024
11 GBE1 NM_000158.3(GBE1): c.839G> A (p.Gly280Asp) single nucleotide variant Benign/Likely benign rs28763902 GRCh37 Chromosome 3, 81692085: 81692085
12 GBE1 NM_000158.3(GBE1): c.839G> A (p.Gly280Asp) single nucleotide variant Benign/Likely benign rs28763902 GRCh38 Chromosome 3, 81642934: 81642934
13 GBE1 NM_000158.3(GBE1): c.579G> A (p.Lys193=) single nucleotide variant Benign rs17019144 GRCh37 Chromosome 3, 81698119: 81698119
14 GBE1 NM_000158.3(GBE1): c.579G> A (p.Lys193=) single nucleotide variant Benign rs17019144 GRCh38 Chromosome 3, 81648968: 81648968
15 GBE1 NM_000158.3(GBE1): c.342C> T (p.Tyr114=) single nucleotide variant Benign rs13320194 GRCh37 Chromosome 3, 81720076: 81720076
16 GBE1 NM_000158.3(GBE1): c.342C> T (p.Tyr114=) single nucleotide variant Benign rs13320194 GRCh38 Chromosome 3, 81670925: 81670925
17 GBE1 NM_000158.3(GBE1): c.176T> C (p.Ile59Thr) single nucleotide variant Benign/Likely benign rs28763904 GRCh37 Chromosome 3, 81754732: 81754732
18 GBE1 NM_000158.3(GBE1): c.176T> C (p.Ile59Thr) single nucleotide variant Benign/Likely benign rs28763904 GRCh38 Chromosome 3, 81705581: 81705581
19 GBE1 NM_000158.3(GBE1): c.143+10G> T single nucleotide variant Benign/Likely benign rs9820490 GRCh37 Chromosome 3, 81810516: 81810516
20 GBE1 NM_000158.3(GBE1): c.143+10G> T single nucleotide variant Benign/Likely benign rs9820490 GRCh38 Chromosome 3, 81761365: 81761365
21 GBE1 NM_000158.3(GBE1): c.1581G> A (p.Thr527=) single nucleotide variant Uncertain significance rs140571802 GRCh38 Chromosome 3, 81577962: 81577962
22 GBE1 NM_000158.3(GBE1): c.1581G> A (p.Thr527=) single nucleotide variant Uncertain significance rs140571802 GRCh37 Chromosome 3, 81627113: 81627113
23 GBE1 NM_000158.3(GBE1): c.1406A> G (p.Tyr469Cys) single nucleotide variant Uncertain significance rs760661724 GRCh38 Chromosome 3, 81581205: 81581205
24 GBE1 NM_000158.3(GBE1): c.1406A> G (p.Tyr469Cys) single nucleotide variant Uncertain significance rs760661724 GRCh37 Chromosome 3, 81630356: 81630356
25 GBE1 NM_000158.3(GBE1): c.647A> G (p.Tyr216Cys) single nucleotide variant Uncertain significance rs886058901 GRCh38 Chromosome 3, 81648900: 81648900
26 GBE1 NM_000158.3(GBE1): c.647A> G (p.Tyr216Cys) single nucleotide variant Uncertain significance rs886058901 GRCh37 Chromosome 3, 81698051: 81698051
27 GBE1 NM_000158.3(GBE1): c.-102C> T single nucleotide variant Likely benign rs886058903 GRCh38 Chromosome 3, 81761618: 81761618
28 GBE1 NM_000158.3(GBE1): c.-102C> T single nucleotide variant Likely benign rs886058903 GRCh37 Chromosome 3, 81810769: 81810769
29 GBE1 NM_000158.3(GBE1): c.*558T> C single nucleotide variant Uncertain significance rs886058899 GRCh38 Chromosome 3, 81489849: 81489849
30 GBE1 NM_000158.3(GBE1): c.*558T> C single nucleotide variant Uncertain significance rs886058899 GRCh37 Chromosome 3, 81539000: 81539000
31 GBE1 NM_000158.3(GBE1): c.*466G> A single nucleotide variant Uncertain significance rs571158601 GRCh38 Chromosome 3, 81489941: 81489941
32 GBE1 NM_000158.3(GBE1): c.*466G> A single nucleotide variant Uncertain significance rs571158601 GRCh37 Chromosome 3, 81539092: 81539092
33 GBE1 NM_000158.3(GBE1): c.*176G> A single nucleotide variant Benign rs846 GRCh38 Chromosome 3, 81490231: 81490231
34 GBE1 NM_000158.3(GBE1): c.*176G> A single nucleotide variant Benign rs846 GRCh37 Chromosome 3, 81539382: 81539382
35 GBE1 NM_000158.3(GBE1): c.1874T> G (p.Phe625Cys) single nucleotide variant Uncertain significance rs769567764 GRCh38 Chromosome 3, 81535255: 81535255
36 GBE1 NM_000158.3(GBE1): c.1874T> G (p.Phe625Cys) single nucleotide variant Uncertain significance rs769567764 GRCh37 Chromosome 3, 81584406: 81584406
37 GBE1 NM_000158.3(GBE1): c.1392C> T (p.Leu464=) single nucleotide variant Uncertain significance rs563241317 GRCh38 Chromosome 3, 81581219: 81581219
38 GBE1 NM_000158.3(GBE1): c.1392C> T (p.Leu464=) single nucleotide variant Uncertain significance rs563241317 GRCh37 Chromosome 3, 81630370: 81630370
39 GBE1 NM_000158.3(GBE1): c.*395A> G single nucleotide variant Uncertain significance rs138608612 GRCh38 Chromosome 3, 81490012: 81490012
40 GBE1 NM_000158.3(GBE1): c.*395A> G single nucleotide variant Uncertain significance rs138608612 GRCh37 Chromosome 3, 81539163: 81539163
41 GBE1 NM_000158.3(GBE1): c.1803G> A (p.Gln601=) single nucleotide variant Uncertain significance rs368793136 GRCh38 Chromosome 3, 81536911: 81536911
42 GBE1 NM_000158.3(GBE1): c.1803G> A (p.Gln601=) single nucleotide variant Uncertain significance rs368793136 GRCh37 Chromosome 3, 81586062: 81586062
43 GBE1 NM_000158.3(GBE1): c.859G> C (p.Val287Leu) single nucleotide variant Uncertain significance rs116899644 GRCh38 Chromosome 3, 81642914: 81642914
44 GBE1 NM_000158.3(GBE1): c.859G> C (p.Val287Leu) single nucleotide variant Uncertain significance rs116899644 GRCh37 Chromosome 3, 81692065: 81692065
45 GBE1 NM_000158.3(GBE1): c.144-7T> C single nucleotide variant Uncertain significance rs886058902 GRCh38 Chromosome 3, 81705620: 81705620
46 GBE1 NM_000158.3(GBE1): c.144-7T> C single nucleotide variant Uncertain significance rs886058902 GRCh37 Chromosome 3, 81754771: 81754771
47 GBE1 NM_000158.3(GBE1): c.*598G> C single nucleotide variant Uncertain significance rs886058898 GRCh38 Chromosome 3, 81489809: 81489809
48 GBE1 NM_000158.3(GBE1): c.*598G> C single nucleotide variant Uncertain significance rs886058898 GRCh37 Chromosome 3, 81538960: 81538960
49 GBE1 NM_000158.3(GBE1): c.*555G> A single nucleotide variant Uncertain significance rs143820392 GRCh38 Chromosome 3, 81489852: 81489852
50 GBE1 NM_000158.3(GBE1): c.*555G> A single nucleotide variant Uncertain significance rs143820392 GRCh37 Chromosome 3, 81539003: 81539003

Expression for Adult Polyglucosan Body Disease

Search GEO for disease gene expression data for Adult Polyglucosan Body Disease.

Pathways for Adult Polyglucosan Body Disease

GO Terms for Adult Polyglucosan Body Disease

Sources for Adult Polyglucosan Body Disease

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
Content
Loading form....